TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 21 filers reported holding TRILLIUM THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $622,000 | -76.0% | 110,000 | -37.1% | 0.37% | -73.0% |
| Q3 2016 | $2,587,000 | +47.7% | 175,000 | -10.3% | 1.35% | +15.7% |
| Q2 2016 | $1,751,000 | -2.9% | 195,000 | 0.0% | 1.17% | +4.0% |
| Q1 2016 | $1,804,000 | -31.9% | 195,000 | -7.1% | 1.12% | +1.6% |
| Q4 2015 | $2,648,000 | -17.1% | 210,000 | -14.4% | 1.11% | -29.6% |
| Q3 2015 | $3,196,000 | -41.4% | 245,275 | -1.9% | 1.57% | -27.5% |
| Q2 2015 | $5,455,000 | +3.7% | 250,000 | -3.8% | 2.17% | -11.1% |
| Q1 2015 | $5,260,000 | +75.3% | 260,000 | -22.0% | 2.44% | +61.1% |
| Q4 2014 | $3,000,000 | – | 333,333 | – | 1.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|